This Controversial Cancer Test Just Passed a Key FDA Vote. Here’s Why It’s Dividing Experts
Grail’s Galleri test costs $1,000 and promises comprehensive early-stage screening for more than 50 types of cancer.
We haven't written up this one. Inc. has the full story — the link below goes straight to it.